Rockefeller Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-637
| Closed | -$24K | – | 3333 |
|
|
2022
Q4 | $24K | Sell |
637
-278
| -30% | -$10.5K | ﹤0.01% | 2734 |
|
|
2022
Q3 | $48K | Sell |
915
-149
| -14% | -$7.82K | ﹤0.01% | 2371 |
|
|
2022
Q2 | $61K | Buy |
1,064
+81
| +8% | +$4.64K | ﹤0.01% | 2197 |
|
|
2022
Q1 | $75K | Buy |
983
+7
| +0.7% | +$534 | ﹤0.01% | 2117 |
|
|
2021
Q4 | $58K | Sell |
976
-189
| -16% | -$11.2K | ﹤0.01% | 2150 |
|
|
2021
Q3 | $65K | Buy |
1,165
+32
| +3% | +$1.79K | ﹤0.01% | 2021 |
|
|
2021
Q2 | $68K | Buy |
1,133
+83
| +8% | +$4.98K | ﹤0.01% | 1946 |
|
|
2021
Q1 | $73K | Buy |
1,050
+13
| +1% | +$904 | ﹤0.01% | 1746 |
|
|
2020
Q4 | $62K | Buy |
1,037
+133
| +15% | +$7.95K | ﹤0.01% | 1610 |
|
|
2020
Q3 | $54K | Buy |
904
+603
| +200% | +$36K | ﹤0.01% | 1486 |
|
|
2020
Q2 | $16K | Sell |
301
-62
| -17% | -$3.3K | ﹤0.01% | 1747 |
|
|
2020
Q1 | $12K | Buy |
363
+163
| +82% | +$5.39K | ﹤0.01% | 1691 |
|
|
2019
Q4 | $9K | Hold |
200
| – | – | ﹤0.01% | 1641 |
|
|
2019
Q3 | $8K | Buy |
+200
| New | +$8K | ﹤0.01% | 1498 |
|
|
2019
Q2 | – | Sell |
-163
| Closed | -$6K | – | 1891 |
|
|
2019
Q1 | $6K | Buy |
+163
| New | +$6K | ﹤0.01% | 1599 |
|